Hong Kong stock market anomaly | AstraZeneca vaccine (06660.HK) rose more than 8% during trading, recently completed the board of directors' change, the company accelerates the "H+A" strategic layout.

According to the "Zhitong Finance" app, Amoy Biopharmaceuticals (06660.HK) rose more than 8% in mid-trading session, and as of the time of writing, it had increased by 7.65% to 1.83 Hong Kong dollars.